Table 1.

Mean dose, dose range, number of patients treated, and CAR T-cell products used in published reports of bridging RT regimens used in patients awaiting CAR T-cell delivery

Mean dose	Dose range	# Patients treated	CAR T-cell product	Institution	Ref
37.5 Gy	20–45 Gy in 2.2–4 Gy fractions	5	3 Tisa-cel, 2 Axi-cel	UPenn	34
20 Gy	6–36.5 Gy in 2–4 Gy fractions; half received either 4 Gy x 5 or 3 Gy x 10	12	Axi-cel	Moffitt	32
35.2 Gy	10–45 Gy in 1.8–2.6 Gy fractions	17	Axi-cel	MDACC	33

CAR, Chimeric Antigen Receptor.